T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.66B |
| 2 |
PPL
PPL Corp
PPL
|
+$1.29B |
| 3 |
Abbott
ABT
|
+$1.23B |
| 4 |
NVIDIA
NVDA
|
+$1.02B |
| 5 |
Broadcom
AVGO
|
+$974M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roper Technologies
ROP
|
+$1.21B |
| 2 |
Amphenol
APH
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$1.03B |
| 4 |
Autodesk
ADSK
|
+$1.02B |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$858M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.78% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 14.43% |
| 4 | Financials | 10.54% |
| 5 | Industrials | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Merit Medical Systems
MMSI
$5.45B
| $3K | ﹤0.01% |
+25
| New | +$2.18K |
|
827
Murphy USA
MUSA
$10.1B
| $3K | ﹤0.01% |
+6
| New | +$2.38K |
|
828
Insperity
NSP
$1.97B
| $3K | ﹤0.01% |
+50
| New | +$2.74K |
|
829
Natera
NTRA
$45B
| $3K | ﹤0.01% |
+18
| New | +$2.85K |
|
830
Envista
NVST
$4.62B
| $3K | ﹤0.01% |
+101
| New | +$2.08K |
|
831
Progress Software
PRGS
$1.79B
| $3K | ﹤0.01% |
+48
| New | +$2.21K |
|
832
Royal Caribbean
RCL
$83.5B
| $3K | ﹤0.01% |
+8
| New | +$2.67K |
|
833
ResMed
RMD
$32.8B
| $3K | ﹤0.01% |
+8
| New | +$2.19K |
|
834
SM Energy
SM
$7.6B
| $3K | ﹤0.01% |
+103
| New | +$2.78K |
|
|
THS
835
DELISTED
Treehouse Foods
THS
| $3K | ﹤0.01% |
121
-2,894,245
| -100% | -$54.9M |
|
836
TKO Group
TKO
$14.4B
| $3K | ﹤0.01% |
+11
| New | +$2.01K |
|
837
Tyson Foods
TSN
$19.9B
| $3K | ﹤0.01% |
+44
| New | +$2.43K |
|
838
UGI
UGI
$7.6B
| $3K | ﹤0.01% |
+77
| New | +$2.69K |
|
839
Williams-Sonoma
WSM
$29B
| $3K | ﹤0.01% |
+12
| New | +$2.29K |
|
840
Dentsply Sirona
XRAY
$2.32B
| $3K | ﹤0.01% |
+205
| New | +$2.98K |
|
841
Solventum
SOLV
$14.7B
| $3K | ﹤0.01% |
34
-97
| -74% | -$7.11K |
|
842
Archer Daniels Midland
ADM
$38.7B
| $2K | ﹤0.01% |
+33
| New | +$1.93K |
|
843
Boise Cascade
BCC
$2.97B
| $2K | ﹤0.01% |
+18
| New | +$1.54K |
|
844
Certara
CERT
$1.22B
| $2K | ﹤0.01% |
+143
| New | +$1.56K |
|
845
Chemed
CHE
$7.04B
| $2K | ﹤0.01% |
+4
| New | +$1.81K |
|
846
Dollar General
DG
$27B
| $2K | ﹤0.01% |
+15
| New | +$1.65K |
|
847
Equity Lifestyle Properties
ELS
$12.6B
| $2K | ﹤0.01% |
+27
| New | +$1.64K |
|
848
EPAM Systems
EPAM
$5.23B
| $2K | ﹤0.01% |
+7
| New | +$1.15K |
|
849
Exponent
EXPO
$3.23B
| $2K | ﹤0.01% |
+23
| New | +$1.64K |
|
850
EyePoint Inc
EYPT
$1.16B
| $2K | ﹤0.01% |
+80
| New | +$921 |
|
Similar funds
T. Rowe Price Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Investment Management held 939 positions worth $164B, up 3.3% from $158B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
T. Rowe Price Investment Management's Q3 2025 filing shows 254 new, 274 increased, 349 reduced and 60 closed positions. Its largest new stake was PPL Corp: 35,967,694 shares worth $1.34B. The largest sale was Roper Technologies, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q3 2025 buy was PPL Corp: 35,967,694 shares worth $1.34B.
- T. Rowe Price Investment Management added most to Apple in Q3 2025, an estimated $2.66B increase.
- T. Rowe Price Investment Management's biggest Q3 2025 reduction was Roper Technologies, cutting an estimated $1.21B.
- T. Rowe Price Investment Management fully exited RTX Corp in Q3 2025, selling an estimated $634M.
- T. Rowe Price Investment Management's ten largest holdings make up 23% of its $164B portfolio in Q3 2025.
- T. Rowe Price Investment Management opened 254 new positions and closed 60 in Q3 2025.
- T. Rowe Price Investment Management's portfolio value rose 3.3% quarter-over-quarter to $164B.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.